Esra Kaytan

639 total citations
18 papers, 480 citations indexed

About

Esra Kaytan is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Esra Kaytan has authored 18 papers receiving a total of 480 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 7 papers in Surgery. Recurrent topics in Esra Kaytan's work include Head and Neck Cancer Studies (4 papers), Sarcoma Diagnosis and Treatment (3 papers) and Viral-associated cancers and disorders (3 papers). Esra Kaytan is often cited by papers focused on Head and Neck Cancer Studies (4 papers), Sarcoma Diagnosis and Treatment (3 papers) and Viral-associated cancers and disorders (3 papers). Esra Kaytan collaborates with scholars based in Türkiye. Esra Kaytan's co-authors include İnci̇ Ayan, Erkan Topuz, Nuri Faruk Aykan, Süleyman Alıcı, Burak Sakar, Adnan Aydıner, Faruk Taş, Yeşim Eralp, Mert Başaran and Haluk Onat and has published in prestigious journals such as The Lancet Oncology, International Journal of Radiation Oncology*Biology*Physics and Lung Cancer.

In The Last Decade

Esra Kaytan

16 papers receiving 468 citations

Peers

Esra Kaytan

ONCOL

PRM

SURGE

OTORH

PFM

Hiroyuki Kawakami Japan

Juliette Haudebourg France

Melvin L. Reed United States

Anne-Birgitte Jacobsen Norway

Swee‐Peng Yap Singapore

Ülkü Yalçıntaş Arslan Türkiye

Shoji Terui Japan

Jere T. W. Licciardello United States

K. Khanfir Switzerland

Edward Rosenblatt Israel

Hiroyuki Kawakami Japan

Esra Kaytan

205 ×0.9

ONCOL

179 ×0.9

PRM

184 ×1.1

SURGE

35 ×0.3

OTORH

125 ×1.1

PFM

Citations per year, relative to Esra Kaytan Esra Kaytan (= 1×) peers Hiroyuki Kawakami

Countries citing papers authored by Esra Kaytan

Since Specialization

Citations

This map shows the geographic impact of Esra Kaytan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esra Kaytan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esra Kaytan more than expected).

Fields of papers citing papers by Esra Kaytan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esra Kaytan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esra Kaytan. The network helps show where Esra Kaytan may publish in the future.

Co-authorship network of co-authors of Esra Kaytan

This figure shows the co-authorship network connecting the top 25 collaborators of Esra Kaytan. A scholar is included among the top collaborators of Esra Kaytan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esra Kaytan. Esra Kaytan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Alıcı, Süleyman, et al.. (2012). Survival outcomes in aggressive non-Hodgkin's lymphoma according to the International Prognostic Index.. PubMed. 8(2). 121–6.

Saynak, Mert, Güzide Aksu, Merdan Fayda, et al.. (2012). The results of concomitant and sequential chemoradiotherapy with cisplatin and etoposide in patients with locally advanced non-small cell lung cancer.. PubMed. 10(2). 213–8.

Sakar, Burak, Hakan Karagöl, Mahmut Gümüş, et al.. (2004). Timing of Death From Tumor Recurrence After Curative Gastrectomy for Gastric Cancer. American Journal of Clinical Oncology. 27(2). 205–209. 45 indexed citations

Altun, Musa, Ayşe Nur Demiral, Esra Kaytan, et al.. (2004). Prognostic significance of hemoglobin concentration in nasopharyngeal carcinoma: does treatment-induced anemia have negative effect?. PubMed. 17(5). 483–7. 6 indexed citations

Kaytan, Esra, et al.. (2003). Prognostic Factors in Localized Soft-Tissue Sarcomas. American Journal of Clinical Oncology. 26(4). 411–415. 15 indexed citations

Alıcı, Süleyman, Sevil Bavbek, Esra Kaytan, Yeşim Eralp, & Haluk Onat. (2003). Prognostic Factors in Localized Aggressive Non-Hodgkin’s Lymphoma. American Journal of Clinical Oncology. 26(1). 1–5. 13 indexed citations

Eralp, Yeşim, et al.. (2003). Resectable Thymoma: Treatment Outcome and Prognostic Factors in the Late Adolescent and Adult Age Group. Cancer Investigation. 21(5). 737–743. 14 indexed citations

Alıcı, Süleyman, et al.. (2003). Colorectal Cancer in Young Patients: Characteristics and Outcome. The Tohoku Journal of Experimental Medicine. 199(2). 85–93. 84 indexed citations

Ayan, İnci̇, et al.. (2003). Childhood nasopharyngeal carcinoma: from biology to treatment. The Lancet Oncology. 4(1). 13–21. 130 indexed citations

10.

Kaytan, Esra, et al.. (2003). . American Journal of Clinical Oncology. 26(4). 411–415. 1 indexed citations

11.

Eralp, Yeşim, et al.. (2003). 130 Resectable thymoma: treatment outcome and prognostic factors in the late adolescent and adult age group. European Journal of Cancer Supplements. 1(5). S43–S44. 1 indexed citations

12.

Alıcı, Süleyman, Sevil Bavbek, Esra Kaytan, et al.. (2002). Aggressive Non-Hodgkin’s Lymphoma Treated at the Institute of Oncology, Istanbul. American Journal of Clinical Oncology. 25(5). 502–508. 2 indexed citations

13.

İşbir, Turgay, İlhan Yaylım, Soykan Arıkan, et al.. (2002). Close correlation between restriction fragment length polymorphism of L-myc gene and susceptibility to gastric cancer. Cancer Detection and Prevention. 26(6). 454–457. 7 indexed citations

14.

Eralp, Yeşim, Sevil Bavbek, Mert Başaran, et al.. (2002). Prognostic Factors and Survival in Late Adolescent and Adult Patients With Small Round Cell Tumors. American Journal of Clinical Oncology. 25(4). 418–424. 25 indexed citations

15.

Onat, Haluk, Mert Başaran, Sevil Bavbek, et al.. (2002). High-dose Epirubicin and Cisplatin in Locally Advanced Undifferentiated Nasopharyngeal Carcinoma. Clinical Oncology. 14(6). 449–454. 7 indexed citations

16.

Taş, Faruk, Nuri Faruk Aykan, Süleyman Alıcı, et al.. (2001). Prognostic Factors in Pancreatic Carcinoma. American Journal of Clinical Oncology. 24(6). 547–550. 90 indexed citations

17.

Altun, Musa, et al.. (2000). Locally advanced nasopharyngeal carcinoma: computed tomography findings, clinical evaluation, and treatment outcome∗. International Journal of Radiation Oncology*Biology*Physics. 47(2). 401–404. 13 indexed citations

18.

Oral, Ethem Nezih, et al.. (1999). Preliminary analysis of a phase II study of Paclitaxel and CHART in locally advanced non-small cell lung cancer. Lung Cancer. 25(3). 191–198. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact